Trial intelligence / Profile preview

Human Mesenchymal Stem Cell Conditioned Medium for Cancer Cachexia and Treatment-Related Symptoms

jRCT1051240096Recruiting

Sponsor
Image Guided Therapy
Start
Feb 2024
Countries
1
01

Overview

Open-label, single-arm trial in cancer anorexia-cachexia syndrome (CACS), cancer therapy toxicity and cancer, sponsored by Image Guided Therapy. Primary endpoints: Medical records, Period of cancer and 1 more. Started Feb 2024; status: recruiting.

02

Conditions

cancer anorexia-cachexia syndrome (CACS)cancer therapy toxicitycancer

Beyond the preview

Go deeper on jRCT1051240096.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1051240096.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call